参考文献/References:
[1]Russo M,Owen R,Bernard A,et al.Evaluation of accuracy and reproducibility of a relocatable maxillary fixation system for fractionated intracranial stereotactic radiation therapy[J].J Med Radiat Sci,2016,63(1):41-47. [2]吴志勤,张力,余建义,等.肺癌图像引导放疗不同配准方式对摆位误差的影响[J].温州医科大学学报,2014,44(11):822-824. [3]Wan H,Bertholet J,Ge J,et al.Automated patient setup and gating using cone beam computed tomography projections[J].Phys Med Biol,2016,61(6):2552-2561. [4]王恩阳,徐飞,贾明轩.应用千伏级锥形束对非小细胞肺癌立体定向放疗外放边界研究[J].中国和杂志,2016,5(2):37-39. [5]Borst GR,Sonke JJ,Betgen A,et al.Kilo-voltage conebeam computed tomography setup measurements for lung cancer patients:first clinical results and comparison with electronic portal imaging device[J].Int J Radiat Oncol Biol Phys,2007,68(2):555-561. [6]Duggan DM,Ding GX,Coffey CW,et al.Deep-inspiration breath-hold kilovoltage cone beam CT for setup of stereotactic body radiation therapy for lung tumors:Initial experience[J].Lung Cancer,2007,56(1):77-88. [7]戴建荣,胡逸民.图像引导放疗的实现方式[J].中华放射肿瘤学杂志,2006,15(2):132-135. [8]Verellen D,De Ridder M,Storme G.A(short)history of image guided radiotherapy[J].Radiothert Oncol,2008,86(1):4-13. [9]李庆瑞,陈吉祥,丁大庆,等.不同人员对肺癌图像配准误差分析[J].实用癌症杂志,2018,33(8):1245-1248. [10]顾浩,樊锐太,郭跃信,等.锥形束图像引导用于胸部肿瘤放射治疗的效果分析[J].临床研究,2016,24(4):83-84. [11]Heinz C,Gerum S,Freislederer P,et al.Feasibility study on image guided patient positioning for stereotactic body radiation therapy of liver malignancies guided by liver motion[J].Radiat Oncol,2016,27(11):88. [12]孙小喆,孟慧鹏,郑爱青,等.肺癌影像引导放疗摆位误差及配准的对比研究[J].医疗卫生装备,2017,38(11):69-78.
相似文献/References:
[1]尤 静.肺癌患者外周血CEA、NSE、CYFRA21-1联合检测的意义[J].医学信息,2018,31(06):149.[doi:10.3969/j.issn.1006-1959.2018.06.052]
YOU Jing.Clinical Significance of Combined Detection of CEA,NSE,CYFRA21-1 in Peripheral Blood of Patients with Lung Cancer[J].Medical Information,2018,31(19):149.[doi:10.3969/j.issn.1006-1959.2018.06.052]
[2]戴 芳,曹晓美,王莉娜.肺癌患者疾病不确定感的影响因素与干预措施研究现状[J].医学信息,2018,31(08):35.[doi:10.3969/j.issn.1006-1959.2018.08.012]
DAI Fang,CAO Xiao-mei,WANG Li-na.Research Status on Influencing Factors and Intervention Measures of Disease Uncertainty in Patients with Lung Cancer[J].Medical Information,2018,31(19):35.[doi:10.3969/j.issn.1006-1959.2018.08.012]
[3]吴 倩,王一非.中西医结合治疗肺癌脑转移疗效与安全性的Meta分析[J].医学信息,2022,35(10):120.[doi:10.3969/j.issn.1006-1959.2022.10.029]
WU Qian,WANG Yi-fei.Meta-analysis of Efficacy and Safety of Integrated Traditional Chinese and Western Medicine in the Treatment of Brain Metastasis of Lung Cancer[J].Medical Information,2022,35(19):120.[doi:10.3969/j.issn.1006-1959.2022.10.029]
[4]王晓军.以时间护理为基础的呼吸训练与排痰管理对肺癌手术患者康复的影响研究[J].医学信息,2022,35(11):180.[doi:10.3969/j.issn.1006-1959.2022.11.048]
WANG Xiao-jun.Effect of Respiratory Training and Expectoration Management Based on Time Nursing on Rehabilitation of Patients with Lung Cancer Surgery[J].Medical Information,2022,35(19):180.[doi:10.3969/j.issn.1006-1959.2022.11.048]
[5]邢益辉,刘 曼,厉玛倩倩,等.快速康复对肺癌手术患者并发症发生及生活质量的影响研究[J].医学信息,2018,31(16):168.[doi:10.3969/j.issn.1006-1959.2018.16.054]
XING Yi-hui,LIU Man,LIMA Qian-qian,et al.Effect of Rapid Rehabilitation on Complications and Quality of Life in Patients with Lung Cancer Surgery[J].Medical Information,2018,31(19):168.[doi:10.3969/j.issn.1006-1959.2018.16.054]
[6]朱晓晓,张 顺,蔡 挺.镍暴露相关的肺癌发生分子机制研究[J].医学信息,2018,31(17):4.[doi:10.3969/j.issn.1006-1959.2018.17.002]
ZHU Xiao-xiao,ZHANG Shun,CAI Ting.Molecular Mechanism of Lung Cancer Related to Nickel Exposure[J].Medical Information,2018,31(19):4.[doi:10.3969/j.issn.1006-1959.2018.17.002]
[7]付云杰.肺癌患者血浆D-二聚体、NSE及CYFRA21-1联合检测的临床价值[J].医学信息,2018,31(23):161.[doi:10.3969/j.issn.1006-1959.2018.23.047]
FU Yun-jie.Clinical Value of the Plasma D-dimer and Serum NSE,CYFRA21-1 Combined Detection in the Diagnosis of Lung Cancer[J].Medical Information,2018,31(19):161.[doi:10.3969/j.issn.1006-1959.2018.23.047]
[8]覃柳麻,何慧敏.2014~2016年广西肿瘤医院肺癌患者流行病学及病理分布特征分析[J].医学信息,2019,32(05):67.[doi:10.3969/j.issn.1006-1959.2019.05.021]
QIN Liu-ma,HE Hui-min.Epidemiological and Pathological Distribution Characteristics of Lung Cancer Patients in Guangxi Cancer Hospital from 2014 to 2016[J].Medical Information,2019,32(19):67.[doi:10.3969/j.issn.1006-1959.2019.05.021]
[9]魏优蕾,郭晓彤.肺癌患者血浆检测肿瘤标志物的分析方法及展望[J].医学信息,2019,32(07):39.[doi:10.3969/j.issn.1006-1959.2019.07.014]
WEI You-lei,GUO Xiao-Tong.Analytical Methods and Prospects of Plasma Detection of Tumor Markers in Patients with Lung Cancer[J].Medical Information,2019,32(19):39.[doi:10.3969/j.issn.1006-1959.2019.07.014]
[10]杨寿林,宋庆志,吴路发,等.肿瘤标志物和凝血指标在肺癌辅助诊断中的效果分析[J].医学信息,2019,32(07):168.[doi:10.3969/j.issn.1006-1959.2019.07.053]
YANG Shou-lin,SONG Qing-zhi,WU Lu-fa,et al.Efficacy Analysis of Tumor Markers and Coagulation Parameters in the Diagnosis of Lung Cancer[J].Medical Information,2019,32(19):168.[doi:10.3969/j.issn.1006-1959.2019.07.053]